Prostate Cancer Therapeutics Market Size, Share & Growth Report 2032

Prostate Cancer Therapeutics Market

Prostate Cancer Therapeutics Market By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, And Biologic Therapy), By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, And Others), and By Region: Global Industry Perspective, Size, Trends, Comprehensive Analysis, And Forecast, 2024 – 2032

Category: Pharmaceutical Report Format : PDF Pages: 240 Report Code: ZMR-2320 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 12.84 Billion USD 24.74 Billion 7.68% 2023

Prostate Cancer Therapeutics Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter 1. Executive Summary 19
  • Chapter 2. Prostate Cancer Therapeutics market - Therapy Analysis 21
    • 2.1. Global Prostate Cancer Therapeutics Market - Therapy Overview 21
    • 2.2. Global Prostate Cancer Therapeutics Market Share, by Therapy, 2024 & 2032 (USD Billion) 21
    • 2.3. Hormone Therapy 23
      • 2.3.1. Global Hormone Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 23
    • 2.4. Targeted Therapy 24
      • 2.4.1. Global Targeted Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 24
    • 2.5. Chemotherapy 25
      • 2.5.1. Global Chemotherapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 25
    • 2.6. Biologic Therapy 26
      • 2.6.1. Global Biologic Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 26
  • Chapter 3. Prostate Cancer Therapeutics market - Distribution Channel Analysis 26
    • 3.1. Global Prostate Cancer Therapeutics Market - Distribution Channel Overview 26
    • 3.2. Global Prostate Cancer Therapeutics Market Share, by Distribution Channel, 2024 & 2032 (USD Billion) 27
    • 3.3. Hospital Pharmacies 28
      • 3.3.1. Global Hospital Pharmacies Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 28
    • 3.4. Online Sales 29
      • 3.4.1. Global Online Sales Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 29
    • 3.5. Retail Pharmacies 30
      • 3.5.1. Global Retail Pharmacies Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 30
    • 3.6. Others 31
      • 3.6.1. Global Others Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion) 31
  • Chapter 4. Prostate Cancer Therapeutics market - Regional Analysis 32
    • 4.1. Global Prostate Cancer Therapeutics Market Regional Overview 32
    • 4.2. Global Prostate Cancer Therapeutics Market Share, by Region, 2024 & 2032 (Value) 32
    • 4.3. North America 34
      • 4.3.1. North America Prostate Cancer Therapeutics Market size and forecast, 2024-2032 34
      • 4.3.2. North America Prostate Cancer Therapeutics Market, by Country, 2024 & 2032 (USD Billion) 34
      • 4.3.3. North America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 36
        • 4.3.3.1. North America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion) 36
      • 4.3.4. North America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 37
        • 4.3.4.1. North America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion) 37
      • 4.3.5. U.S. 38
        • 4.3.5.1. U.S. Market size and forecast, 2024-2032 (USD Billion) 38
      • 4.3.6. Canada 39
        • 4.3.6.1. Canada Market size and forecast, 2024-2032 (USD Billion) 39
    • 4.4. Europe 40
      • 4.4.1. Europe Prostate Cancer Therapeutics Market size and forecast, 2024-2032 40
      • 4.4.2. Europe Prostate Cancer Therapeutics Market, by Country, 2024 & 2032 (USD Billion) 40
      • 4.4.3. Europe Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 42
        • 4.4.3.1. Europe Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion) 42
      • 4.4.4. Europe Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 43
        • 4.4.4.1. Europe Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion) 43
      • 4.4.5. Germany 44
        • 4.4.5.1. Germany Market size and forecast, 2024-2032 (USD Billion) 44
      • 4.4.6. France 45
        • 4.4.6.1. France Market size and forecast, 2024-2032 (USD Billion) 45
      • 4.4.7. U.K. 46
        • 4.4.7.1. U.K. Market size and forecast, 2024-2032 (USD Billion) 46
      • 4.4.8. Italy 47
        • 4.4.8.1. Italy Market size and forecast, 2024-2032 (USD Billion) 47
      • 4.4.9. Spain 48
        • 4.4.9.1. Spain Market size and forecast, 2024-2032 (USD Billion) 48
      • 4.4.10. Rest of Europe 49
        • 4.4.10.1. Rest of Europe Market size and forecast, 2024-2032 (USD Billion) 49
    • 4.5. Asia Pacific 50
      • 4.5.1. Asia Pacific Prostate Cancer Therapeutics Market size and forecast, 2024-2032 50
      • 4.5.2. Asia Pacific Prostate Cancer Therapeutics Market, by Country, 2024 & 2032 (USD Billion) 50
      • 4.5.3. Asia Pacific Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 52
        • 4.5.3.1. Asia Pacific Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion) 52
      • 4.5.4. Asia Pacific Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 53
      • 4.5.4.1. Asia Pacific Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion) 53
      • 4.5.5. China 54
        • 4.5.5.1. China Market size and forecast, 2024-2032 (USD Billion) 54
      • 4.5.6. Japan 55
        • 4.5.6.1. Japan Market size and forecast, 2024-2032 (USD Billion) 55
      • 4.5.7. India 56
        • 4.5.7.1. India Market size and forecast, 2024-2032 (USD Billion) 56
      • 4.5.8. South Korea 57
        • 4.5.8.1. South Korea Market size and forecast, 2024-2032 (USD Billion) 57
      • 4.5.9. South-East Asia 58
        • 4.5.9.1. South-East Asia Market size and forecast, 2024-2032 (USD Billion) 58
      • 4.5.10. Rest of Asia Pacific 59
        • 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2024-2032 (USD Billion) 59
    • 4.6. Latin America 60
      • 4.6.1. Latin America Prostate Cancer Therapeutics Market size and forecast, 2024-2032 60
      • 4.6.2. Latin America Prostate Cancer Therapeutics Market, by Country, 2024 & 2032 (USD Billion) 60
      • 4.6.3. Latin America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 62
        • 4.6.3.1. Latin America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion) 62
      • 4.6.4. Latin America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 63
        • 4.6.4.1. Latin America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion) 63
      • 4.6.5. Brazil 64
        • 4.6.5.1. Brazil Market size and forecast, 2024-2032 (USD Billion) 64
      • 4.6.6. Mexico 65
        • 4.6.6.1. Mexico Market size and forecast, 2024-2032 (USD Billion) 65
      • 4.6.7. Rest of Latin America 66
        • 4.6.7.1. Rest of Latin America Market size and forecast, 2024-2032 (USD Billion) 66
    • 4.7. The Middle-East and Africa 67
      • 4.7.1. The Middle-East and Africa Prostate Cancer Therapeutics Market size and forecast, 2024-2032 67
      • 4.7.2. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Country, 2024 & 2032 (USD Billion) 67
      • 4.7.3. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 69
        • 4.7.3.1. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion) 69
      • 4.7.4. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 70
        • 4.7.4.1. The Middle-East and Africa Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion) 70
      • 4.7.5. GCC Countries 71
        • 4.7.5.1. GCC Countries Market size and forecast, 2024-2032 (USD Billion) 71
      • 4.7.6. South Africa 72
        • 4.7.6.1. South Africa Market size and forecast, 2024-2032 (USD Billion) 72
      • 4.7.7. Rest of Middle-East Africa 73
        • 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2024-2032 (USD Billion) 73
  • Chapter 5. Prostate Cancer Therapeutics market - Competitive Landscape 74
    • 5.1. Competitor Market Share - Revenue 74
    • 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 76
    • 5.3. Strategic Development 77
      • 5.3.1. Acquisitions and Mergers 77
      • 5.3.2. New Products 77
      • 5.3.3. Research & Development Activities 77
  • Chapter 6. Company Profiles 78
    • 6.1. Bayer AG 78
      • 6.1.1. Company Overview 78
      • 6.1.2. Bayer AG Revenue and Gross Margin 78
      • 6.1.3. Product portfolio 79
      • 6.1.4. Recent initiatives 80
    • 6.2. Johnson & Johnson 80
      • 6.2.1. Company Overview 80
      • 6.2.2. Johnson & Johnson Revenue and Gross Margin 80
      • 6.2.3. Product portfolio 81
      • 6.2.4. Recent initiatives 82
    • 6.3. Ipsen Group 82
      • 6.3.1. Company Overview 82
      • 6.3.2. Ipsen Group Revenue and Gross Margin 82
      • 6.3.3. Product portfolio 83
      • 6.3.4. Recent initiatives 84
    • 6.4. Amgen Inc. 84
      • 6.4.1. Company Overview 84
      • 6.4.2. Amgen Inc. Revenue and Gross Margin 84
      • 6.4.3. Product portfolio 85
      • 6.4.4. Recent initiatives 86
    • 6.5. Endo Pharmaceuticals Inc. 86
      • 6.5.1. Company Overview 86
      • 6.5.2. Endo Pharmaceuticals Inc. Revenue and Gross Margin 86
      • 6.5.3. Product portfolio 87
      • 6.5.4. Recent initiatives 88
    • 6.6. AbbVie Inc. 88
      • 6.6.1. Company Overview 88
      • 6.6.2. AbbVie Inc. Revenue and Gross Margin 88
      • 6.6.3. Product portfolio 89
      • 6.6.4. Recent initiatives 90
    • 6.7. Pfizer Inc. 90
      • 6.7.1. Company Overview 90
      • 6.7.2. Pfizer Inc. Revenue and Gross Margin 90
      • 6.7.3. Product portfolio 91
      • 6.7.4. Recent initiatives 92
    • 6.8. AstraZeneca 92
      • 6.8.1. Company Overview 92
      • 6.8.2. AstraZeneca Revenue and Gross Margin 92
      • 6.8.3. Product portfolio 93
      • 6.8.4. Recent initiatives 94
    • 6.9. Sanofi 94
      • 6.9.1. Company Overview 94
      • 6.9.2. Sanofi Revenue and Gross Margin 94
      • 6.9.3. Product portfolio 95
      • 6.9.4. Recent initiatives 96
    • 6.10. Sanpower Group 96
      • 6.10.1. Company Overview 96
      • 6.10.2. Sanpower Group Revenue and Gross Margin 96
      • 6.10.3. Product portfolio 97
      • 6.10.4. Recent initiatives 98
  • Chapter 7. Prostate Cancer Therapeutics — Industry Analysis 99
    • 7.1. Prostate Cancer Therapeutics Market - Key Trends 99
      • 7.1.1. Market Drivers 100
      • 7.1.2. Market Restraints 100
      • 7.1.3. Market Opportunities 101
    • 7.2. Value Chain Analysis 102
    • 7.3. Technology Roadmap and Timeline 103
    • 7.4. Prostate Cancer Therapeutics Market - Attractiveness Analysis 104
      • 7.4.1. By Therapy 104
      • 7.4.2. By Distribution Channel 104
      • 7.4.3. By Region 106
  • Chapter 8. Marketing Strategy Analysis, Distributors 107
    • 8.1. Marketing Channel 107
    • 8.2. Direct Marketing 108
    • 8.3. Indirect Marketing 108
    • 8.4. Marketing Channel Development Trend 108
    • 8.5. Economic/Political Environmental Change 109
  • Chapter 9. Report Conclusion 110
  • Chapter 10. Research Approach & Methodology 111
    • 10.1. Report Description 111
    • 10.2. Research Scope 112
    • 10.3. Research Methodology 112
      • 10.3.1. Secondary Research 113
      • 10.3.2. Primary Research 114
      • 10.3.3. Models 115
        • 10.3.3.1. Company Share Analysis Model 115
        • 10.3.3.2. Revenue Based Modeling 116
        • 10.3.3.3. Research Limitations 116

Table Of Figures

LIST OF FIGURES

1.    Global Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    21
2.    Global Prostate Cancer Therapeutics Market Share, by Therapy, 2024 & 2032 (USD Billion)    22
3.    Global Hormone Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    24
4.    Global Targeted Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    25
5.    Global Chemotherapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    26
6.    Global Biologic Therapy Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    27
7.    Global Prostate Cancer Therapeutics Market Share, by Distribution Channel, 2024 & 2032 (USD Billion)    28
8.    Global Hospital Pharmacies Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    29
9.    Global Online Sales Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    30
10.    Global Retail Pharmacies Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    31
11.    Global Others Prostate Cancer Therapeutics Market, 2024-2032 (USD Billion)    32
12.    Global Prostate Cancer Therapeutics Market Share, by Region, 2024 & 2032    33
13.    North America Prostate Cancer Therapeutics Market, 2024-2032    35
14.    U.S. Prostate Cancer Therapeutics Market, 2024-2032    39
15.    Canada Prostate Cancer Therapeutics Market, 2024-2032    40
16.    Europe Prostate Cancer Therapeutics Market, 2024-2032    41
17.    Germany Prostate Cancer Therapeutics Market, 2024-2032    45
18.    France Prostate Cancer Therapeutics Market, 2024-2032    46
19.    U.K. Prostate Cancer Therapeutics Market, 2024-2032    47
20.    Italy Prostate Cancer Therapeutics Market, 2024-2032    48
21.    Spain Prostate Cancer Therapeutics Market, 2024-2032    49
22.    Rest of Europe Prostate Cancer Therapeutics Market, 2024-2032    50
23.    Asia Pacific Prostate Cancer Therapeutics Market, 2024-2032    51
24.    China Prostate Cancer Therapeutics Market, 2024-2032    55
25.    Japan Prostate Cancer Therapeutics Market, 2024-2032    56
26.    India Prostate Cancer Therapeutics Market, 2024-2032    57
27.    South  Korea Prostate Cancer Therapeutics Market, 2024-2032    58
28.    South-East Asia Prostate Cancer Therapeutics Market, 2024-2032    59
29.    Rest of Asia Pacific Prostate Cancer Therapeutics Market, 2024-2032    60
30.    Latin America Prostate Cancer Therapeutics Market, 2024-2032    61
31.    Brazil Prostate Cancer Therapeutics Market, 2024-2032    65
32.    Mexico Prostate Cancer Therapeutics Market, 2024-2032    66
33.    Rest of Latin America Prostate Cancer Therapeutics Market, 2024-2032    67
34.    The Middle-East and Africa Prostate Cancer Therapeutics Market, 2024-2032    68
35.    GCC Countries Prostate Cancer Therapeutics Market, 2024-2032    72
36.    South Africa Prostate Cancer Therapeutics Market, 2024-2032    73
37.    Rest of Middle-East Africa Prostate Cancer Therapeutics Market, 2024-2032    74
38.    Competitor Market Share – Revenue    75
39.    Bayer AG Revenue and Growth Rate    80
40.    Bayer AG Market Share    80
41.    Johnson & Johnson Revenue and Growth Rate    82
42.    Johnson & Johnson Market Share    82
43.    Ipsen Group Revenue and Growth Rate    84
44.    Ipsen Group Market Share    84
45.    Amgen Inc. Revenue and Growth Rate    86
46.    Amgen Inc. Market Share    86
47.    Endo Pharmaceuticals Inc. Revenue and Growth Rate    88
48.    Endo Pharmaceuticals Inc. Market Share    88
49.    AbbVie Inc. Revenue and Growth Rate    90
50.    AbbVie Inc. Market Share    90
51.    Pfizer Inc. Revenue and Growth Rate    92
52.    Pfizer Inc. Market Share    92
53.    AstraZeneca Revenue and Growth Rate    94
54.    AstraZeneca Market Share    94
55.    Sanofi Revenue and Growth Rate    96
56.    Sanofi Market Share    96
57.    Sanpower Group Revenue and Growth Rate    98
58.    Sanpower Group Market Share    98
59.    Market Dynamics    100
60.    Global Prostate Cancer Therapeutics – Value Chain Analysis    103
61.    Technology Roadmap and Timeline    104
62.    Market Attractiveness Analysis – By Therapy    105
63.    Market Attractiveness Analysis – By Distribution Channel    106
64.    Market Attractiveness Analysis – By Region    107
65.    Market Channel    108
66.    Marketing Channel Development Trend    109
67.    Growth in World Gross Product, 2008-2024    110


Table Of Tables

LIST OF TABLES

1.    Global Prostate Cancer Therapeutics Market, 2024 & 2032 (USD Billion)    20
2.    Global Prostate Cancer Therapeutics market, by Therapy, 2024-2032 (USD Billion)    22
3.    Global Prostate Cancer Therapeutics market, by Distribution Channel, 2024-2032 (USD Billion)    28
4.    Global Prostate Cancer Therapeutics market, by Region, 2024-2032 (USD Billion)    33
5.    North America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion)    37
6.    North America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion)    38
7.    Europe Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion)    43
8.    Europe Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion)    44
9.    Asia Pacific Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion)    53
10.    Asia Pacific Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion)    54
11.    Latin America Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion)    63
12.    Latin America Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Mllion)    64
13.    The Middle-East and Africa Prostate Cancer Therapeutics Market, by Therapy, 2024-2032 (USD Billion)    70
14.    The Middle-East and Africa Prostate Cancer Therapeutics Market, by Distribution Channel, 2024-2032 (USD Billion)    71
15.    Global Prostate Cancer Therapeutics Market - Company Revenue Analysis 2024-2032 (USD Billion)    75
16.    Global Prostate Cancer Therapeutics Market - Company Revenue Share Analysis 2024-2032(%)    77
17.    Acquisitions and Mergers    78
18.    New Product/Service Launch    78
19.    Research & Development Activities    78
20.    Market Drivers    101
21.    Market Restraints    101
22.    Market Opportunities    102

Methodology

FrequentlyAsked Questions

Prostate cancer therapeutics are treatments designed to fight prostate cancer. These can include medications, surgery, radiation, and other approaches.
 

According to a study, the global prostate cancer therapeutics market size was worth around USD 12.84 billion in 2023 and is expected to reach USD 24.74 billion by 2032.
 

The global prostate cancer therapeutics market is expected to grow at a CAGR of 7.68% during the forecast period.
 

North America is expected to dominate the prostate cancer therapeutics market over the forecast period.
 

Leading players in the global prostate cancer therapeutics market include Bayer AG, Johnson & Johnson, Ipsen Group, Amgen, Inc., Endo Pharmaceuticals, Inc., AbbVie, Inc., Pfizer, Inc., AstraZeneca, Sanofi, Sanpower Group, among others.

The prostate cancer therapeutics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed